

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.56926816 |
| 2 | viral transcription (GO:0019083) | 5.37301978 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.35972536 |
| 4 | protein targeting to ER (GO:0045047) | 5.22583263 |
| 5 | cotranslational protein targeting to membrane (GO:0006613) | 5.21398219 |
| 6 | translational termination (GO:0006415) | 5.16537862 |
| 7 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.95629766 |
| 8 | protein localization to endoplasmic reticulum (GO:0070972) | 4.92751772 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 4.82284935 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.82284935 |
| 11 | translational elongation (GO:0006414) | 4.68874809 |
| 12 | signal peptide processing (GO:0006465) | 4.63641963 |
| 13 | DNA deamination (GO:0045006) | 4.60455419 |
| 14 | viral life cycle (GO:0019058) | 4.42842213 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 4.20931850 |
| 16 | tolerance induction (GO:0002507) | 4.20008721 |
| 17 | protein maturation by protein folding (GO:0022417) | 4.19402257 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.15575415 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.13336789 |
| 20 | * translational initiation (GO:0006413) | 4.12330165 |
| 21 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.09316265 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 4.07508543 |
| 23 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.90806970 |
| 24 | translation (GO:0006412) | 3.87066510 |
| 25 | regulation of chronic inflammatory response (GO:0002676) | 3.74621897 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.65086494 |
| 27 | proteasome assembly (GO:0043248) | 3.63508953 |
| 28 | protein targeting to membrane (GO:0006612) | 3.58711930 |
| 29 | protein complex disassembly (GO:0043241) | 3.52690280 |
| 30 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.49415565 |
| 31 | positive regulation of granulocyte differentiation (GO:0030854) | 3.48713457 |
| 32 | ATP synthesis coupled proton transport (GO:0015986) | 3.42790668 |
| 33 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.42790668 |
| 34 | macromolecular complex disassembly (GO:0032984) | 3.42749394 |
| 35 | protein complex biogenesis (GO:0070271) | 3.39296861 |
| 36 | regulation of mitochondrial translation (GO:0070129) | 3.39223592 |
| 37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.38800966 |
| 38 | termination of RNA polymerase III transcription (GO:0006386) | 3.38800966 |
| 39 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.38563324 |
| 40 | viral protein processing (GO:0019082) | 3.37118313 |
| 41 | respiratory electron transport chain (GO:0022904) | 3.36613910 |
| 42 | electron transport chain (GO:0022900) | 3.31797720 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.31650033 |
| 44 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.28618213 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 3.28305275 |
| 46 | cullin deneddylation (GO:0010388) | 3.24801730 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.24396252 |
| 48 | virion assembly (GO:0019068) | 3.23002176 |
| 49 | protein deneddylation (GO:0000338) | 3.18420620 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18303124 |
| 51 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.17906990 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 3.14944570 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12882716 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.12882716 |
| 55 | NADH metabolic process (GO:0006734) | 3.12583698 |
| 56 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.11293675 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.11110892 |
| 58 | cellular component biogenesis (GO:0044085) | 3.10175370 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.06901709 |
| 60 | amino acid salvage (GO:0043102) | 2.98584519 |
| 61 | L-methionine salvage (GO:0071267) | 2.98584519 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 2.98584519 |
| 63 | peptidyl-histidine modification (GO:0018202) | 2.98364799 |
| 64 | T-helper cell differentiation (GO:0042093) | 2.95438081 |
| 65 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.95438081 |
| 66 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.95279954 |
| 67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.91935524 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.90912494 |
| 69 | oxidative phosphorylation (GO:0006119) | 2.89157767 |
| 70 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.88520410 |
| 71 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.86202205 |
| 72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.86202205 |
| 73 | NADH dehydrogenase complex assembly (GO:0010257) | 2.86202205 |
| 74 | protein K11-linked ubiquitination (GO:0070979) | 2.84011138 |
| 75 | rRNA modification (GO:0000154) | 2.83347969 |
| 76 | metallo-sulfur cluster assembly (GO:0031163) | 2.83305396 |
| 77 | iron-sulfur cluster assembly (GO:0016226) | 2.83305396 |
| 78 | negative regulation of ligase activity (GO:0051352) | 2.83229596 |
| 79 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.83229596 |
| 80 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.83202968 |
| 81 | protein retention in ER lumen (GO:0006621) | 2.82538979 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81914637 |
| 83 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81914637 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.81808746 |
| 85 | positive regulation of mitochondrial fission (GO:0090141) | 2.81731316 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.81582553 |
| 87 | interferon-gamma production (GO:0032609) | 2.80485477 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.79582114 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79498604 |
| 90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78863503 |
| 91 | sequestering of actin monomers (GO:0042989) | 2.78011911 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77266998 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.74654339 |
| 94 | RNA destabilization (GO:0050779) | 2.74567597 |
| 95 | positive regulation of DNA recombination (GO:0045911) | 2.73520361 |
| 96 | positive regulation of ligase activity (GO:0051351) | 2.73511468 |
| 97 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.72493859 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.70727305 |
| 99 | mRNA catabolic process (GO:0006402) | 2.69580728 |
| 100 | oxaloacetate metabolic process (GO:0006107) | 2.67776032 |
| 101 | establishment of protein localization to membrane (GO:0090150) | 2.66450377 |
| 102 | spliceosomal snRNP assembly (GO:0000387) | 2.65297190 |
| 103 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.64691721 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.64493275 |
| 105 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.64343790 |
| 106 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.64343790 |
| 107 | mast cell activation (GO:0045576) | 2.64272896 |
| 108 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.63714897 |
| 109 | ribosome biogenesis (GO:0042254) | 2.63564049 |
| 110 | T cell differentiation involved in immune response (GO:0002292) | 2.63209817 |
| 111 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.63209817 |
| 112 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.63209817 |
| 113 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62566678 |
| 114 | respiratory chain complex IV assembly (GO:0008535) | 2.62099815 |
| 115 | regulation of immunoglobulin secretion (GO:0051023) | 2.61168954 |
| 116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60539157 |
| 117 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.59249539 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.57719093 |
| 119 | protein neddylation (GO:0045116) | 2.56214263 |
| 120 | GTP biosynthetic process (GO:0006183) | 2.55942728 |
| 121 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.55879407 |
| 122 | cytochrome complex assembly (GO:0017004) | 2.55342448 |
| 123 | spliceosomal complex assembly (GO:0000245) | 2.54333725 |
| 124 | chaperone-mediated protein transport (GO:0072321) | 2.54278129 |
| 125 | negative T cell selection (GO:0043383) | 2.54043918 |
| 126 | heme biosynthetic process (GO:0006783) | 2.53956335 |
| 127 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.53405442 |
| 128 | regulation of germinal center formation (GO:0002634) | 2.53306144 |
| 129 | negative thymic T cell selection (GO:0045060) | 2.53217733 |
| 130 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52927226 |
| 131 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52927226 |
| 132 | pseudouridine synthesis (GO:0001522) | 2.52807777 |
| 133 | de novo protein folding (GO:0006458) | 2.51990356 |
| 134 | positive regulation of isotype switching (GO:0045830) | 2.51660516 |
| 135 | autophagic vacuole fusion (GO:0000046) | 2.51494561 |
| 136 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.51287149 |
| 137 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49904553 |
| 138 | rRNA processing (GO:0006364) | 2.49889403 |
| 139 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.47154693 |
| 140 | positive regulation of protein homooligomerization (GO:0032464) | 2.45133971 |
| 141 | defense response to protozoan (GO:0042832) | 2.44983344 |
| 142 | neutrophil activation (GO:0042119) | 2.43861538 |
| 143 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.42528520 |
| 144 | alpha-beta T cell activation (GO:0046631) | 2.38713081 |
| 145 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.38236620 |
| 146 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.37908016 |
| 147 | piRNA metabolic process (GO:0034587) | 2.36865712 |
| 148 | positive regulation of interleukin-17 production (GO:0032740) | 2.36660752 |
| 149 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.35897636 |
| 150 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35778490 |
| 151 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.35655751 |
| 152 | phagosome maturation (GO:0090382) | 2.35512377 |
| 153 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.35170767 |
| 154 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.34170849 |
| 155 | response to protozoan (GO:0001562) | 2.34130895 |
| 156 | alpha-beta T cell differentiation (GO:0046632) | 2.33687347 |
| 157 | organelle membrane fusion (GO:0090174) | 2.33516422 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.33134712 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.33134712 |
| 160 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.31994727 |
| 161 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.31727318 |
| 162 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.31011662 |
| 163 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.30639270 |
| 164 | negative regulation of acute inflammatory response (GO:0002674) | 2.30399454 |
| 165 | regulation of vacuole organization (GO:0044088) | 2.28714316 |
| 166 | granulocyte activation (GO:0036230) | 2.27123007 |
| 167 | protein-cofactor linkage (GO:0018065) | 2.25275086 |
| 168 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.24667420 |
| 169 | platelet dense granule organization (GO:0060155) | 2.24009424 |
| 170 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.23394124 |
| 171 | negative regulation of innate immune response (GO:0045824) | 2.23288839 |
| 172 | sleep (GO:0030431) | 2.23180943 |
| 173 | negative regulation of bone resorption (GO:0045779) | 2.21093739 |
| 174 | actin nucleation (GO:0045010) | 2.21071615 |
| 175 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.21046868 |
| 176 | positive regulation of B cell mediated immunity (GO:0002714) | 2.21046868 |
| 177 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.20543601 |
| 178 | regulation of T-helper cell differentiation (GO:0045622) | 2.19229820 |
| 179 | regulation of granulocyte differentiation (GO:0030852) | 2.18078135 |
| 180 | leukocyte degranulation (GO:0043299) | 2.16575533 |
| 181 | positive regulation of interleukin-2 production (GO:0032743) | 2.16299371 |
| 182 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.16250280 |
| 183 | cellular response to interleukin-15 (GO:0071350) | 2.15310814 |
| 184 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.15268130 |
| 185 | transferrin transport (GO:0033572) | 2.14286218 |
| 186 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.14093717 |
| 187 | mast cell degranulation (GO:0043303) | 2.13993273 |
| 188 | mast cell activation involved in immune response (GO:0002279) | 2.13993273 |
| 189 | regulation of defense response to virus by host (GO:0050691) | 2.13761223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.10704219 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.65865660 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.49726259 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45899846 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.34739770 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.33078927 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.19590651 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.16339928 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12417883 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11568527 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11246676 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.10156423 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.71056932 |
| 14 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.59687605 |
| 15 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.52028574 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.49025240 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.48887944 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.46716482 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43358811 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34835097 |
| 21 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15818816 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.14353905 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13336945 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08941131 |
| 25 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.07193560 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.06354047 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05553144 |
| 28 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03047145 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02455175 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.01536977 |
| 31 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.99041780 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.93943628 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88897535 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87179058 |
| 35 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85531654 |
| 36 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.85411849 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84695425 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.83670124 |
| 39 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76978858 |
| 40 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.75274588 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71306468 |
| 42 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.71208402 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70327598 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69845012 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69149392 |
| 46 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68268683 |
| 47 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.64480349 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64006467 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.57734153 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56292665 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.55684345 |
| 52 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54770178 |
| 53 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54717874 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54372566 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.53636416 |
| 56 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.51958947 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49053617 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48699110 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46952085 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46845302 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41437981 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40681303 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40659018 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39440882 |
| 65 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.39215667 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.38032113 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37923622 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37106180 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36148844 |
| 70 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35670232 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33848769 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32381532 |
| 73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32356529 |
| 74 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31107649 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29160364 |
| 76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.29026846 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27897227 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27386315 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26880323 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26072484 |
| 81 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24747179 |
| 82 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.23946583 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21746519 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21372989 |
| 85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20540369 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20145546 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19108371 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16201026 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15576983 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15546414 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14287422 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14207275 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13240779 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12907777 |
| 95 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.12052392 |
| 96 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12005213 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11799436 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11768039 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11403733 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10859297 |
| 101 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10547660 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10137537 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09838172 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09679296 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08347387 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08160607 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07583183 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07072065 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05179225 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.04077068 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03497979 |
| 112 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03480670 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00950152 |
| 114 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00321936 |
| 115 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00181252 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99863090 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99834384 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98744247 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98208694 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97211797 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97046113 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96058882 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95934326 |
| 124 | * MYB_26560356_Chip-Seq_TH2_Human | 0.95913031 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95770899 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94990146 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94863982 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94373353 |
| 129 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94017652 |
| 130 | P300_27268052_Chip-Seq_Bcells_Human | 0.93805631 |
| 131 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93360634 |
| 132 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93261387 |
| 133 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93130274 |
| 134 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91683105 |
| 135 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91492365 |
| 136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89688536 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89663360 |
| 138 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88436379 |
| 139 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88070359 |
| 140 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.88014475 |
| 141 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87119713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.76697461 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 2.94942138 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 2.76045035 |
| 4 | MP0000013_abnormal_adipose_tissue | 2.56280276 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.36740396 |
| 6 | MP0003724_increased_susceptibility_to | 2.36197746 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.32187361 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.30526786 |
| 9 | MP0005671_abnormal_response_to | 2.14628749 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.12258605 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.10768413 |
| 12 | MP0002693_abnormal_pancreas_physiology | 2.09368934 |
| 13 | MP0004043_abnormal_pH_regulation | 2.02984190 |
| 14 | MP0000678_abnormal_parathyroid_gland | 2.02756418 |
| 15 | MP0000685_abnormal_immune_system | 2.00254995 |
| 16 | MP0001944_abnormal_pancreas_morphology | 1.97765569 |
| 17 | MP0003866_abnormal_defecation | 1.90891332 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 1.85493851 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.85366523 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.82800789 |
| 21 | MP0003303_peritoneal_inflammation | 1.79481627 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 1.79045040 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.77780234 |
| 24 | MP0002419_abnormal_innate_immunity | 1.76960438 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.76309235 |
| 26 | MP0009840_abnormal_foam_cell | 1.73078607 |
| 27 | MP0003123_paternal_imprinting | 1.72660910 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.71659017 |
| 29 | MP0004510_myositis | 1.69272321 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.66593451 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.61668543 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.60421382 |
| 33 | MP0008995_early_reproductive_senescence | 1.59712165 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.59577629 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.58682160 |
| 36 | MP0001873_stomach_inflammation | 1.58428847 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.58193928 |
| 38 | MP0003436_decreased_susceptibility_to | 1.56133781 |
| 39 | MP0005387_immune_system_phenotype | 1.53711258 |
| 40 | MP0001790_abnormal_immune_system | 1.53711258 |
| 41 | MP0003646_muscle_fatigue | 1.48591190 |
| 42 | MP0009764_decreased_sensitivity_to | 1.48356253 |
| 43 | MP0000490_abnormal_crypts_of | 1.47176953 |
| 44 | MP0008932_abnormal_embryonic_tissue | 1.46874373 |
| 45 | MP0003186_abnormal_redox_activity | 1.45944190 |
| 46 | MP0008004_abnormal_stomach_pH | 1.44514137 |
| 47 | MP0006054_spinal_hemorrhage | 1.42443830 |
| 48 | MP0009785_altered_susceptibility_to | 1.41287816 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.39023656 |
| 50 | MP0002132_abnormal_respiratory_system | 1.38999329 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.37203371 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.36102069 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.35906258 |
| 54 | MP0001542_abnormal_bone_strength | 1.35655417 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.34987380 |
| 56 | MP0000858_altered_metastatic_potential | 1.34506867 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.33063680 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.26634017 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.25834886 |
| 60 | MP0002163_abnormal_gland_morphology | 1.24936848 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.24710816 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.24388069 |
| 63 | MP0003077_abnormal_cell_cycle | 1.23895308 |
| 64 | MP0002933_joint_inflammation | 1.22812965 |
| 65 | MP0002723_abnormal_immune_serum | 1.22180465 |
| 66 | MP0002398_abnormal_bone_marrow | 1.22075275 |
| 67 | MP0005535_abnormal_body_temperature | 1.21620005 |
| 68 | MP0002405_respiratory_system_inflammati | 1.20268314 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.19105038 |
| 70 | MP0004147_increased_porphyrin_level | 1.18898617 |
| 71 | MP0009278_abnormal_bone_marrow | 1.18855479 |
| 72 | MP0004947_skin_inflammation | 1.18361158 |
| 73 | MP0000003_abnormal_adipose_tissue | 1.18072650 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.16537441 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.15353396 |
| 76 | MP0001819_abnormal_immune_cell | 1.14999237 |
| 77 | MP0005025_abnormal_response_to | 1.14864130 |
| 78 | MP0000613_abnormal_salivary_gland | 1.13436361 |
| 79 | MP0001800_abnormal_humoral_immune | 1.10325994 |
| 80 | MP0001853_heart_inflammation | 1.08943081 |
| 81 | MP0003195_calcinosis | 1.08523564 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.08249661 |
| 83 | MP0001545_abnormal_hematopoietic_system | 1.08249661 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.08048604 |
| 85 | MP0002722_abnormal_immune_system | 1.07644610 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.04936445 |
| 87 | MP0004142_abnormal_muscle_tone | 1.04797900 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.04776688 |
| 89 | MP0001905_abnormal_dopamine_level | 1.04768841 |
| 90 | MP0000343_altered_response_to | 1.04104569 |
| 91 | MP0001835_abnormal_antigen_presentation | 1.03015936 |
| 92 | MP0000716_abnormal_immune_system | 1.02711723 |
| 93 | MP0002452_abnormal_antigen_presenting | 1.02635543 |
| 94 | MP0000689_abnormal_spleen_morphology | 1.01944653 |
| 95 | MP0002429_abnormal_blood_cell | 1.01557949 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 1.01297814 |
| 97 | MP0000749_muscle_degeneration | 1.00890075 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.98280277 |
| 99 | MP0008872_abnormal_physiological_respon | 0.97959985 |
| 100 | MP0005410_abnormal_fertilization | 0.97054496 |
| 101 | MP0003880_abnormal_central_pattern | 0.96626590 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.95922498 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.95199110 |
| 104 | MP0005423_abnormal_somatic_nervous | 0.94841698 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.94042873 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.91577760 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.89326789 |
| 108 | MP0001764_abnormal_homeostasis | 0.88888730 |
| 109 | MP0005083_abnormal_biliary_tract | 0.88685972 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.88433221 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.88367814 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86851083 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.86792930 |
| 114 | MP0001851_eye_inflammation | 0.86690533 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.86298709 |
| 116 | MP0009763_increased_sensitivity_to | 0.86206233 |
| 117 | MP0006082_CNS_inflammation | 0.85922262 |
| 118 | MP0003786_premature_aging | 0.81756557 |
| 119 | MP0001756_abnormal_urination | 0.81287766 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.81230755 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.80840833 |
| 122 | MP0004484_altered_response_of | 0.80783802 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.80445396 |
| 124 | MP0001663_abnormal_digestive_system | 0.80344691 |
| 125 | MP0000313_abnormal_cell_death | 0.80326080 |
| 126 | MP0008469_abnormal_protein_level | 0.79989513 |
| 127 | MP0002822_catalepsy | 0.79701726 |
| 128 | MP0009745_abnormal_behavioral_response | 0.79558030 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.78534458 |
| 130 | MP0005310_abnormal_salivary_gland | 0.77986270 |
| 131 | MP0003075_altered_response_to | 0.77934611 |
| 132 | MP0008260_abnormal_autophagy | 0.76641254 |
| 133 | MP0003828_pulmonary_edema | 0.76323510 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.75589706 |
| 135 | MP0005166_decreased_susceptibility_to | 0.75555274 |
| 136 | MP0005645_abnormal_hypothalamus_physiol | 0.75523955 |
| 137 | MP0003959_abnormal_lean_body | 0.75014529 |
| 138 | MP0008874_decreased_physiological_sensi | 0.74956879 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.74519836 |
| 140 | MP0000358_abnormal_cell_content/ | 0.74484560 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.73876605 |
| 142 | MP0002272_abnormal_nervous_system | 0.72373653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.32485775 |
| 2 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.32485775 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.27402964 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.14898125 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.94325324 |
| 6 | Hepatic necrosis (HP:0002605) | 3.90550039 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.87634607 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.77983334 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 3.69757814 |
| 10 | Acute encephalopathy (HP:0006846) | 3.45536847 |
| 11 | Increased CSF lactate (HP:0002490) | 3.34411570 |
| 12 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.32792671 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.19948342 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.18870800 |
| 15 | Abnormal hemoglobin (HP:0011902) | 3.14128482 |
| 16 | Aplastic anemia (HP:0001915) | 3.05185882 |
| 17 | Trismus (HP:0000211) | 3.04008291 |
| 18 | Reticulocytopenia (HP:0001896) | 2.87870282 |
| 19 | Upper limb muscle weakness (HP:0003484) | 2.87677484 |
| 20 | IgG deficiency (HP:0004315) | 2.85294663 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 2.81764733 |
| 22 | Increased muscle lipid content (HP:0009058) | 2.71900444 |
| 23 | Respiratory failure (HP:0002878) | 2.66771562 |
| 24 | Exertional dyspnea (HP:0002875) | 2.66087159 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 2.62341812 |
| 26 | Cholecystitis (HP:0001082) | 2.62341812 |
| 27 | Oral leukoplakia (HP:0002745) | 2.62034777 |
| 28 | Lactic acidosis (HP:0003128) | 2.61845026 |
| 29 | Petechiae (HP:0000967) | 2.58740919 |
| 30 | Exercise intolerance (HP:0003546) | 2.58720463 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57405167 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57405167 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57405167 |
| 34 | Pallor (HP:0000980) | 2.57157275 |
| 35 | Hypercortisolism (HP:0001578) | 2.57142967 |
| 36 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.57036069 |
| 37 | Macrocytic anemia (HP:0001972) | 2.55443194 |
| 38 | Increased serum lactate (HP:0002151) | 2.54968884 |
| 39 | Late onset (HP:0003584) | 2.54581227 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 2.49600347 |
| 41 | Mutism (HP:0002300) | 2.46867968 |
| 42 | Increased IgM level (HP:0003496) | 2.38125920 |
| 43 | Myositis (HP:0100614) | 2.35208783 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.35175500 |
| 45 | Microretrognathia (HP:0000308) | 2.35127320 |
| 46 | Muscle fiber atrophy (HP:0100295) | 2.33233800 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.31442305 |
| 48 | Degeneration of anterior horn cells (HP:0002398) | 2.30841394 |
| 49 | Abnormality of the anterior horn cell (HP:0006802) | 2.30841394 |
| 50 | Loss of speech (HP:0002371) | 2.29157440 |
| 51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27009143 |
| 52 | Palpitations (HP:0001962) | 2.25491834 |
| 53 | Progressive muscle weakness (HP:0003323) | 2.24787194 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 2.21322847 |
| 55 | Multiple enchondromatosis (HP:0005701) | 2.20876907 |
| 56 | Progressive microcephaly (HP:0000253) | 2.20227705 |
| 57 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18092989 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16089869 |
| 59 | Rough bone trabeculation (HP:0100670) | 2.14421538 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.13903499 |
| 61 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.13465241 |
| 62 | Gout (HP:0001997) | 2.13325408 |
| 63 | Joint swelling (HP:0001386) | 2.12918902 |
| 64 | Type I transferrin isoform profile (HP:0003642) | 2.12636264 |
| 65 | Unilateral renal agenesis (HP:0000122) | 2.12584411 |
| 66 | Symptomatic seizures (HP:0011145) | 2.11860761 |
| 67 | Pheochromocytoma (HP:0002666) | 2.10882890 |
| 68 | Respiratory difficulties (HP:0002880) | 2.10634712 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08619031 |
| 70 | CNS demyelination (HP:0007305) | 2.08199864 |
| 71 | Neoplasm of head and neck (HP:0012288) | 2.07788874 |
| 72 | Esophageal neoplasm (HP:0100751) | 2.07788874 |
| 73 | Thrombocytosis (HP:0001894) | 2.07641723 |
| 74 | Oligomenorrhea (HP:0000876) | 2.07423033 |
| 75 | Papilledema (HP:0001085) | 2.07330271 |
| 76 | Optic neuritis (HP:0100653) | 2.06366720 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 2.06366720 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.03251912 |
| 79 | Vasculitis (HP:0002633) | 2.03166606 |
| 80 | Ventricular fibrillation (HP:0001663) | 2.02367677 |
| 81 | Myopathic facies (HP:0002058) | 2.01762170 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 2.01362387 |
| 83 | Increased serum ferritin (HP:0003281) | 2.01206907 |
| 84 | Parakeratosis (HP:0001036) | 2.00976765 |
| 85 | 11 pairs of ribs (HP:0000878) | 2.00241513 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 1.99781093 |
| 87 | Granulocytopenia (HP:0001913) | 1.99005693 |
| 88 | Abnormality of macrophages (HP:0004311) | 1.98441317 |
| 89 | Metaphyseal dysplasia (HP:0100255) | 1.97902725 |
| 90 | Delusions (HP:0000746) | 1.97022044 |
| 91 | Abnormality of eosinophils (HP:0001879) | 1.96331099 |
| 92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96005449 |
| 93 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96005449 |
| 94 | Abnormal protein glycosylation (HP:0012346) | 1.96005449 |
| 95 | Abnormal glycosylation (HP:0012345) | 1.96005449 |
| 96 | Pulmonary fibrosis (HP:0002206) | 1.95787402 |
| 97 | Cerebral hypomyelination (HP:0006808) | 1.95128007 |
| 98 | Episodic fever (HP:0001954) | 1.94676721 |
| 99 | Fatigue (HP:0012378) | 1.93862316 |
| 100 | Growth hormone excess (HP:0000845) | 1.93690910 |
| 101 | Emotional lability (HP:0000712) | 1.93645924 |
| 102 | Tongue fasciculations (HP:0001308) | 1.93521485 |
| 103 | Mediastinal lymphadenopathy (HP:0100721) | 1.93100654 |
| 104 | Stomatitis (HP:0010280) | 1.91436806 |
| 105 | Abnormality of T cells (HP:0002843) | 1.90516421 |
| 106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90273289 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 1.90273289 |
| 108 | Hyperalaninemia (HP:0003348) | 1.90273289 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.90053372 |
| 110 | Hyperparathyroidism (HP:0000843) | 1.89678304 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 1.89566804 |
| 112 | Panhypogammaglobulinemia (HP:0003139) | 1.88655009 |
| 113 | Poor suck (HP:0002033) | 1.87982226 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.87981482 |
| 115 | Optic disc pallor (HP:0000543) | 1.87846195 |
| 116 | Medial flaring of the eyebrow (HP:0010747) | 1.87315625 |
| 117 | Stomach cancer (HP:0012126) | 1.87299308 |
| 118 | Abnormality of the prostate (HP:0008775) | 1.86537175 |
| 119 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.86412804 |
| 120 | Hypoglycemic seizures (HP:0002173) | 1.86393343 |
| 121 | Neutropenia (HP:0001875) | 1.85648271 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 1.85621514 |
| 123 | Pustule (HP:0200039) | 1.85286866 |
| 124 | Secondary amenorrhea (HP:0000869) | 1.85256303 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.84688538 |
| 126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83109108 |
| 127 | Purpura (HP:0000979) | 1.82492458 |
| 128 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80380020 |
| 129 | Eosinophilia (HP:0001880) | 1.80078407 |
| 130 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.78719490 |
| 131 | Insulin resistance (HP:0000855) | 1.78691092 |
| 132 | Nasal polyposis (HP:0100582) | 1.78533957 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.77648044 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77602342 |
| 135 | Obstructive lung disease (HP:0006536) | 1.77602342 |
| 136 | Progressive neurologic deterioration (HP:0002344) | 1.76731601 |
| 137 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76385571 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76362771 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75726829 |
| 140 | Febrile seizures (HP:0002373) | 1.75671994 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.75257047 |
| 142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75257047 |
| 143 | Irregular epiphyses (HP:0010582) | 1.75094503 |
| 144 | Polycythemia (HP:0001901) | 1.74916337 |
| 145 | Sparse eyelashes (HP:0000653) | 1.74853111 |
| 146 | Abnormality of dental color (HP:0011073) | 1.74818574 |
| 147 | Conjunctival hamartoma (HP:0100780) | 1.74716747 |
| 148 | Large for gestational age (HP:0001520) | 1.74528445 |
| 149 | Orchitis (HP:0100796) | 1.74391282 |
| 150 | Menstrual irregularities (HP:0000858) | 1.74193184 |
| 151 | Type 2 muscle fiber atrophy (HP:0003554) | 1.73631328 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 1.72995780 |
| 153 | Hypergammaglobulinemia (HP:0010702) | 1.72843480 |
| 154 | Polyphagia (HP:0002591) | 1.72391992 |
| 155 | Carpal bone hypoplasia (HP:0001498) | 1.72111194 |
| 156 | Cerebral edema (HP:0002181) | 1.71824244 |
| 157 | Vertebral compression fractures (HP:0002953) | 1.71631033 |
| 158 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.70513013 |
| 159 | Interstitial pulmonary disease (HP:0006530) | 1.70194592 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.70074621 |
| 161 | Alveolar cell carcinoma (HP:0006519) | 1.69011339 |
| 162 | Supranuclear gaze palsy (HP:0000605) | 1.68854974 |
| 163 | Leukocytosis (HP:0001974) | 1.68518322 |
| 164 | Peripheral hypomyelination (HP:0007182) | 1.68391232 |
| 165 | Abnormal pupillary function (HP:0007686) | 1.68389499 |
| 166 | Shoulder girdle muscle weakness (HP:0003547) | 1.67161410 |
| 167 | Eczematoid dermatitis (HP:0000976) | 1.65990282 |
| 168 | Abnormal pancreas size (HP:0012094) | 1.65575143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.50779755 |
| 2 | EIF2AK1 | 2.95662429 |
| 3 | TESK2 | 2.87053941 |
| 4 | MAPK15 | 2.80793665 |
| 5 | PIM2 | 2.75274611 |
| 6 | BUB1 | 2.55242904 |
| 7 | MST4 | 2.43957343 |
| 8 | TESK1 | 2.31195330 |
| 9 | ERN1 | 2.15078965 |
| 10 | TSSK6 | 2.12540360 |
| 11 | TRIB3 | 2.12242903 |
| 12 | NME1 | 2.06256091 |
| 13 | BMPR2 | 2.03904584 |
| 14 | GRK6 | 2.00793659 |
| 15 | IRAK3 | 1.99805098 |
| 16 | TRIM28 | 1.94320512 |
| 17 | PASK | 1.92920149 |
| 18 | RIPK4 | 1.91643941 |
| 19 | MAP3K11 | 1.87500294 |
| 20 | RPS6KA4 | 1.86320599 |
| 21 | MAP4K2 | 1.85706056 |
| 22 | CDK19 | 1.80417953 |
| 23 | STK16 | 1.76833476 |
| 24 | NLK | 1.74526935 |
| 25 | VRK1 | 1.68687676 |
| 26 | LIMK1 | 1.67866659 |
| 27 | MAP4K1 | 1.66824126 |
| 28 | ZAP70 | 1.61890265 |
| 29 | MAP3K12 | 1.57335955 |
| 30 | TBK1 | 1.56589759 |
| 31 | MAP3K5 | 1.54836796 |
| 32 | TXK | 1.54106849 |
| 33 | IRAK1 | 1.53997455 |
| 34 | SIK3 | 1.52600810 |
| 35 | TLK1 | 1.52260257 |
| 36 | FES | 1.48971994 |
| 37 | TAOK2 | 1.46319275 |
| 38 | CCNB1 | 1.44914319 |
| 39 | KDR | 1.44422334 |
| 40 | MAPKAPK3 | 1.40402606 |
| 41 | PINK1 | 1.36446758 |
| 42 | PRPF4B | 1.33945060 |
| 43 | MAP2K2 | 1.25306221 |
| 44 | MAP3K3 | 1.23107909 |
| 45 | BRAF | 1.21987672 |
| 46 | BRSK2 | 1.20577039 |
| 47 | CDK8 | 1.19624849 |
| 48 | DYRK3 | 1.17549462 |
| 49 | HIPK2 | 1.16325963 |
| 50 | SYK | 1.14148034 |
| 51 | BCKDK | 1.10547908 |
| 52 | NEK1 | 1.10224943 |
| 53 | LRRK2 | 1.08923297 |
| 54 | WEE1 | 1.07960193 |
| 55 | SIK2 | 1.07665668 |
| 56 | MATK | 1.06739131 |
| 57 | GRK7 | 1.05350732 |
| 58 | EIF2AK3 | 1.02069524 |
| 59 | TNK2 | 0.97435592 |
| 60 | ACVR1B | 0.96770360 |
| 61 | MAP3K1 | 0.94957952 |
| 62 | MOS | 0.94950223 |
| 63 | EPHA3 | 0.94885404 |
| 64 | ERBB3 | 0.94563783 |
| 65 | TAOK1 | 0.93995087 |
| 66 | JAK3 | 0.93038479 |
| 67 | PIK3CG | 0.92526923 |
| 68 | ADRBK2 | 0.90996278 |
| 69 | ARAF | 0.87110392 |
| 70 | IKBKE | 0.86559246 |
| 71 | TEC | 0.84739561 |
| 72 | LYN | 0.84282379 |
| 73 | BLK | 0.81209456 |
| 74 | DAPK2 | 0.79772404 |
| 75 | FGFR4 | 0.79083449 |
| 76 | NEK9 | 0.78805897 |
| 77 | PHKG1 | 0.78740306 |
| 78 | PHKG2 | 0.78740306 |
| 79 | IKBKB | 0.78212447 |
| 80 | GRK5 | 0.78082969 |
| 81 | KIT | 0.77927723 |
| 82 | TAOK3 | 0.75688401 |
| 83 | PBK | 0.74974773 |
| 84 | MAPK7 | 0.73792029 |
| 85 | DYRK2 | 0.73492730 |
| 86 | AURKA | 0.72928358 |
| 87 | EPHB1 | 0.71532781 |
| 88 | HCK | 0.69963948 |
| 89 | DYRK1B | 0.69797085 |
| 90 | BRSK1 | 0.69604815 |
| 91 | EPHA2 | 0.68769441 |
| 92 | WNK4 | 0.67094689 |
| 93 | PRKCI | 0.66857374 |
| 94 | MARK3 | 0.66490573 |
| 95 | ILK | 0.66248558 |
| 96 | MKNK2 | 0.65938171 |
| 97 | CHUK | 0.64725685 |
| 98 | MAP2K6 | 0.64425146 |
| 99 | MAPK12 | 0.64255891 |
| 100 | PAK6 | 0.63324292 |
| 101 | PRKG2 | 0.62262104 |
| 102 | MAP3K13 | 0.61962352 |
| 103 | PAK4 | 0.61241421 |
| 104 | JAK1 | 0.60610897 |
| 105 | ITK | 0.60597182 |
| 106 | PRKCQ | 0.59199496 |
| 107 | STK24 | 0.56531234 |
| 108 | MAP3K14 | 0.56504853 |
| 109 | MAP2K3 | 0.55404399 |
| 110 | MAPKAPK2 | 0.52462764 |
| 111 | STK10 | 0.51039866 |
| 112 | IRAK4 | 0.50413618 |
| 113 | PDK2 | 0.49656624 |
| 114 | AURKB | 0.49242990 |
| 115 | CSF1R | 0.48379358 |
| 116 | JAK2 | 0.47574680 |
| 117 | TGFBR1 | 0.46645523 |
| 118 | MAPK4 | 0.45057165 |
| 119 | PLK1 | 0.45048468 |
| 120 | PTK2B | 0.44719570 |
| 121 | TYK2 | 0.43178519 |
| 122 | UHMK1 | 0.41437995 |
| 123 | ABL2 | 0.40668856 |
| 124 | SCYL2 | 0.40298317 |
| 125 | DAPK3 | 0.39517445 |
| 126 | PIM1 | 0.39476261 |
| 127 | RPS6KA5 | 0.39439478 |
| 128 | PAK3 | 0.39359745 |
| 129 | GRK1 | 0.39154733 |
| 130 | MUSK | 0.38978269 |
| 131 | PKN1 | 0.38947159 |
| 132 | BMPR1B | 0.38892162 |
| 133 | FLT3 | 0.38133025 |
| 134 | ABL1 | 0.36028821 |
| 135 | NEK2 | 0.34634392 |
| 136 | CSNK1G3 | 0.34571998 |
| 137 | PRKD1 | 0.33123295 |
| 138 | MYLK | 0.33101030 |
| 139 | BCR | 0.32202583 |
| 140 | CSNK2A1 | 0.32073040 |
| 141 | PAK1 | 0.31867872 |
| 142 | BTK | 0.31867723 |
| 143 | DAPK1 | 0.30425974 |
| 144 | CASK | 0.28862124 |
| 145 | LCK | 0.28602908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.74828356 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.23831407 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.39787435 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.39168009 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.20642507 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09537197 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.91592305 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.49670056 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40172375 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.32686149 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.17968432 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.16936513 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.94836725 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.91456430 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87243227 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80664507 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74713891 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.69427514 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64606984 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.61348406 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60456812 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60268460 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44371543 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41489675 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40096573 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.30575418 |
| 27 | * RNA transport_Homo sapiens_hsa03013 | 1.30411614 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29464559 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29280132 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.22288836 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20183476 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17771643 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16894051 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.16695082 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16532115 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16287020 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15456065 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12690395 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.10514610 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07375683 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07155274 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04800429 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02673716 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.01889485 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99162241 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 0.98940213 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96717807 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.94914166 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 0.93850028 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93567338 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.91213362 |
| 52 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88169475 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87165512 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86791211 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80011361 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.78305342 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78214469 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78121481 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76025663 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.74763865 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74180877 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73357935 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72616580 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72101684 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.68795569 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68327240 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66929765 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66129176 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66099470 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65837687 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64660321 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64514578 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64370889 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64076942 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.61514607 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.61183704 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61160940 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59948355 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58756414 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58342644 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.57972622 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57664810 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57590722 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57079148 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56707650 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55591575 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54831711 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54654094 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.54012822 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.53876852 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51249093 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.50144776 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49984743 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49798578 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.49465992 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47777099 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46403162 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44955671 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.43259038 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43164373 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42556083 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.41925583 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41791357 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41772037 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41114354 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40003862 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39127495 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38849071 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38207263 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37264517 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37148795 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34829778 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33258135 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33163476 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.32960224 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32769233 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32235355 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31288061 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31230869 |
| 120 | Tuberculosis_Homo sapiens_hsa05152 | 0.31046157 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.30984358 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30564003 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.29356257 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28917755 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28150612 |
| 126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27893942 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27851572 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27785857 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27635932 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26691789 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26588302 |
| 132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26154725 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.24596338 |
| 134 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.23780932 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.22470419 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21215790 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21108156 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17704678 |

